The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Condition:   Lung Neoplasms Interventions:   Drug: Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy);   Drug: Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy) Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials